Company
Amphista Therapeutics
Amphista Therapeutics is redefining Targeted Protein Degradation.
- Business model
- B2B
- Legal name
- Amphista Therapeutics Limited
Claim, correct or request removal
Record updated 28 September 2026
About
Amphista Therapeutics transforms the lives of patients with severe diseases through advanced, next-generation targeted protein degradation (TPD) medicines.
Products
- Web
- AMX-883
Loading relationship preview